Anzeige
Mehr »
Login
Montag, 20.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
GOLD-MINEN vor Jahrhundert-Hausse?! Diese Aktie sofort kaufen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A403UF | ISIN: SE0022049920 | Ticker-Symbol: LS60
Frankfurt
17.05.24
09:18 Uhr
1,138 Euro
+0,023
+2,04 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
CLINICAL LASERTHERMIA SYSTEMS AB Chart 1 Jahr
5-Tage-Chart
CLINICAL LASERTHERMIA SYSTEMS AB 5-Tage-Chart

Aktuelle News zur CLINICAL LASERTHERMIA SYSTEMS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
25.04.XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 25.04.2024285The following instruments on XETRA do have their first trading 25.04.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 25.04.2024 Aktien 1 CA09263C1068 Blackrock Inc. CDR 2...
► Artikel lesen
24.04.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 24.04.2024335The following instruments on Boerse Frankfurt do have their last trading day on 24.04.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.04.2024.ISIN NameCA56450P2008 MANTARO...
► Artikel lesen
24.04.XFRA ISIN CHANGE353Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS03815U3005 Applied DNA Sciences Inc. 24.04.2024 US03815U4094 Applied DNA Sciences Inc. 25.04.2024 Tausch 20:1CA56450P2008 First...
► Artikel lesen
24.04.Nasdaq Stockholm AB: Reverse Split and Change of ISIN for Clinical Laserthermia Systems AB194Referring to the bulletin from Clinical Laserthermia Systems AB's annual general meeting, held on April 12, 2024, the company will carry out a reverse stock split in relations 1:200. The share will...
► Artikel lesen
24.04.XFRA CAPITAL ADJUSTMENT INFORMATION - 24.04.2024508Das Instrument IQCY LU2023679256 LIF-SM.CIT.ETF DLA ETF wird cum Kapitalmassnahme gehandelt am 24.04.2024 und ex Kapitalmassnahme am 25.04.2024 The instrument IQCY LU2023679256 LIF-SM.CIT.ETF DLA ETF...
► Artikel lesen
19.04.Clinical Laserthermia Systems announces timetable and additional information for the upcoming reverse share split1
12.04.Clinical Laserthermia Systems AB: Bulletin from the Extraordinary General Meeting on Friday 12th of April in Clinical Laserthermia Systems AB2
09.04.Clinical Laserthermia Systems Americas, Inc.: CLS Americas Announces 2nd Order of TRANBERG Focal Laser Ablation Accessories Placed by the National Institutes of Health Clinical Center77LOS ANGELES, April 09, 2024 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems for urologists, today announced...
► Artikel lesen
28.03.Clinical Laserthermia Systems Americas, Inc.: CLS Americas Announces ROSE Urology will use TRANBERG Laser to Treat Prostate Cancer Patients with Focal Laser Ablation3
11.03.Clinical Laserthermia Systems AB: Notice of Extraordinary General Meeting at Clinical Laserthermia Systems AB1
23.02.Clinical Laserthermia Systems AB publishes Year-end report January - December 20231
14.02.Clinical Laserthermia Systems announces that the date for conversion of interim shares is estimated to February 21, 20241
07.02.Clinical Laserthermia Systems will receive ca SEK 23.5 million in connection with the warrant exercise and underwriting commitments for TO 6 B, corresponding to a subscription rate of 100 percent.-
02.02.Clinical Laserthermia Systems AB: Last day of trading in warrants of series TO 6 B is today February 2, 20241
26.01.Clinical Laserthermia Systems AB: Senior executives and larger owner exercise, pro rata, warrants of series TO 6 B for approximately SEK 0.7 million.1
23.01.Clinical Laserthermia Systems AB: The exercise period for warrants of series TO 6 B begins today1
22.01.Clinical Laserthermia Systems AB: The subscription price for warrants of series TO 6 B has been set at SEK 0.10 per share3
17.01.Clinical Laserthermia Systems' business update: focus on accelerating commercial roll-out and updated sales ambitions2
09.01.Clinical Laserthermia Systems receives SEK 8.1 million order from ClearPoint Neuro2
28.12.23Clinical Laserthermia Systems AB: Correction: Clinical Laserthermia Systems nomination committee appointed1
Seite:  Weiter >>
27 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1